BIOCUREX
Biocurex, Inc. is a development-stage company. The Company is focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. The Company has developed a blood test that can detect the presence of cancer in humans and animals using a cancer marker named RECAF. The Company developed and own, royalty-free, the technology related to the RECAF marker. RECAF is a molecule found on cancer cells, including breast, colon, prostate and lung cancers, but not on normal cells. RECAF can be used in blood tests to determine if a patient has cancer. The Company has developed prototype RECAF test kits and materials for small laboratories. Biocurex China Co., Ltd. is the Company's subsidiary.
BIOCUREX
Industry:
Biotechnology Developer Platform Health Diagnostics
Founded:
1997-01-01
Address:
Richmond Hill, Ontario, Canada
Country:
Canada
Total Employee:
1+
Status:
Active
Total Funding:
2.15 M USD
Current Employees Featured
More informations about "BIOCUREX"
BioCurex, Inc. - Richmond, BC, Canada - bionity.com
Nov 8, 2010 BioCurex Inc. is a biotechnology company that is developing products based on patented/proprietary technology for cancer diagnosis and therapy. The core technology …See details»
BioCurex, Inc Company Profile | Richmond, BC, Canada
Find company research, competitor information, contact details & financial data for BioCurex, Inc of Richmond, BC. Get the latest business insights from Dun & Bradstreet.See details»
Microsoft Word - BOCX_EIO_04-11-08 - crystalra.com
April 11, 2008 BioCurex, Inc. (“BioCurex” or “the Company”) is a biotechnology company developing products for cancer diagnosis, imaging, and therapy that target a global oncology …See details»
BioCurex Inc (BOCX) - LinkedIn
BioCurex Inc (BOCX) | 16 followers on LinkedIn.See details»
BioCurex Inc - Company Profile and News - Bloomberg Markets
Company profile page for BioCurex Inc including stock price, company news, executives, board members, and contact informationSee details»
BIOCUREX - Funding, Financials, Valuation & Investors
Biocurex, Inc. is a development-stage company. The Company is focusing on developing and commercializing products for the early detection,See details»
BIOCUREX - Contacts, Employees, Board Members, Advisors
Biocurex, Inc. is a development-stage company. The Company is focusing on developing and commercializing products for the early detection,See details»
BioCurex, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore BioCurex, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
BioCurex Inc. - BioCentury Company Profiles - BCIQ
Jun 11, 2012 BioCurex Inc. - BioCentury Company Profiles for the biopharma industrySee details»
BioCurex, Inc. Executive Chairman Writes to Shareholders
Feb 18, 2010 BioCurex, Inc. is a biotechnology company that is developing products based on patented and proprietary technology in the area of cancer diagnostics. The technology …See details»
BioCurex Appoints Two New Directors - Fierce Biotech
Sep 16, 2009 About BioCurex: BioCurex is a biotechnology company that is developing products based on patented/proprietary technology in the areas of cancer diagnosis, imaging and therapy.See details»
Biocurex : Crystal Research Associates, LLC Issues Executive ...
NEW YORK, April 28 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview (R) (EIO (R)) on BioCurex Inc. (OTC Bulletin …See details»
BioCurex Announces Filing of New Patent For Cancer Diagnostics ...
BioCurex Inc. announced that it has filed a new patent within the Patent Cooperation Treaty, which presently includes 142 countries. The subject of this patent is a synthetic peptide that …See details»
European Patent Office Grants Patent for BioCurex's RECAF Blood …
BioCurex Inc. announced that the European Patent Office (EPO) has granted the Company's patent claims for cancer diagnostic serum tests based on the RECAF marker.See details»
Inverness Inks Licensing Deal with BioCurex to Advance Oncology …
Inverness Medical Innovations licensed BioCurex’ RECAF™ material and technology. RECAF (the receptor for alpha-fetoprotein) is a wide-spectrum marker present in malignant cancer …See details»
BioCurex CEO Highlights Recent Presentation of Its RECAF Test at ...
Sep 20, 2010 BioCurex, Inc. is a biotechnology company that is developing products based on patented and proprietary technology in the area of cancer diagnostics. The technology …See details»
BioCurex Introduces OncoPet A RECAF Blood Test For Cancer …
Aug 9, 2012 A Canadian company, BioCurex, has announced the development of a blood test that can detect cancer in 85% of dogs with 95% accuracy.See details»
BioCurex To Commercialize OncoPet Recaf Test For Cancer …
BioCurex Inc., a biotechnology company developing products based on patented technology in the areas of cancer diagnostics, on Feb. 11 said it has commercialized its OncoPet Recaf test …See details»
BioCurex Announces Filing of New Patent for Cancer Diagnostics ...
Nov 3, 2010 About BioCurex, Inc. BioCurex, Inc. is a biotechnology company that is developing products based on patented and proprietary technology in the area of cancer diagnostics.See details»